Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jun 21, 2022 |
Director, CEO & President
|
Director, CEO & President | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,078,500 | -- |
| Jun 21, 2022 |
Chief Medical Officer
|
Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,488,940 | -- |
| Jun 21, 2022 |
Director, CEO & President
|
Director, CEO & President | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,488,940 | -- |
| Jun 21, 2022 |
EVP & CFO
|
EVP & CFO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,515,957 | -- |
| Jan 09, 2018 |
Director
|
Director | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,500,294 | $18.03 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.